The Lancet & WHO-34 Äڷγª¹ÙÀÌ·¯½º (COVID-19) ¾÷µ¥ÀÌÆ®
COVID-19 Highlights (2020³â 2¿ù 24ÀÏ WHO -Situation Report 34)
- 28°³±¹¿¡¼ 78,811¸íÀÌ Äڷγª¹ÙÀÌ·¯½º(COVID-19)·Î È®Áø º¸°í µÊ
- ÀÌ Áß Áß±¹¿¡¼ 77,042¸í, Áß±¹ ¿Ü ±¹°¡¿¡¼ 1,769¸í È®Áø ȯÀÚ ¹ß»ý
- Äڷγª¹ÙÀÌ·¯½º °¨¿°À¸·Î ÃÑ 2,445¸í »ç¸Á
COVID-19
|
¼¼°èº¸°Ç±â±¸(WHO) À§Çè¼öÁØ °æ°í |
Áß±¹(China)
|
Very High |
Áö¿ªº° À§Çè¼öÁØ(Regional Level)
|
High |
¼¼°èÀû À§Çè¼öÁØ |
High
|
¼¼°è COVID-19 È®Áø »ç·Ê (2020³â 2¿ù 23ÀÏÀÚ, WHO º¸°í)
- Globally : 78,811¸í È®Áø (1,017¸í ½Å±Ô)
- China : 77,042¸í È®Áø(650¸í ½Å±Ô)
- 2,445¸í »ç¸Á (97¸í ½Å±Ô)
Áß±¹ ¿Ü ±¹°¡µé (2020³â 2¿ù 23ÀÏÀÚ, WHO º¸°í)
-1,769¸í È®Áø(367¸í ½Å±Ô)
-28°³±¹ (2°³±¹ ½Å±Ô)
-17¸í »ç¸Á(6¸í ½Å±Ô)
±×¸² 1. Äڷγª¹ÙÀÌ·¯½º°¨¿°(COVID-19) ŸÀÓ¶óÀÎ(Timeline of coronavirus onset)
Source: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China (2020).
The Lancet, DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
±×¸² 2. Áß±¹ ¿ìÇÑ ¹ß¿È¯ÀÚ Äڷγª¹ÙÀÌ·¯½º °¨¿° (COVID-19) Ä¡·á¸¦ À§ÇÑ ÀÓ»óÀü·«
Source: Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics.
Lancet Respir Med 2020; published online Feb 13.
*¾à¾î : CRP=C-reactive protein. CAP=Community-acquired pneumonia.
SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.
±×¸² 3. COVID-19 È®Áø ±¹°¡ ¹× Áö¿ªº° ºÐÆ÷ »óȲ(2020³â 2¿ù 23ÀÏÀÚ WHO º¸°í)
*The situation report includes information provided by national authorities as of 10 AM Central European Time (Source: WHO Coronavirus disease 2019 (COVID-19) Situation Report – 34, https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200223-sitrep-34-covid-19.pdf?sfvrsn=44ff8fd3_2)
±×¸² 4. COVID-19 »ç·ÊÀÇ ¿ªÇкÐÆ÷ °î¼±(Epidemic curve of COVID-19 cases (n=284) identified outside of China,
by date of onset of symptoms and likely exposure location, 23 February 2020
Ç¥ 1. COVID-19 °øÁߺ¸°ÇÀǷḦ À§ÇÑ Á¶±â ¿ªÇÐÀû ÀÓ»óÁ¶»ç ¿¬±¸ ÇÁ·ÎÁ§Æ® ÇöȲ
Ç¥ 2 Áß±¹ ¿Ü Ÿ Áö¿ªº° Äڷγª¹ÙÀÌ·¯½º °¨¿° È®Áø ÇöȲ(2020³â 2¿ù 23ÀÏÀÚ WHO º¸°í)
*The situation report includes information provided by national authorities as of 10 AM Central European Time (Source: WHO Coronavirus disease 2019 (COVID-19) Situation Report – 34, https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200223-sitrep-34-covid-19.pdf?sfvrsn=44ff8fd3_2)
Ç¥ 3. ±¹³» ¹× ±¹¿Ü Äڷγª°¨¿°(COVID-19) ÃÖ±Ù ¾÷µ¥ÀÌÆ®
±¸ºÐ |
¸µÅ© |
Áúº´°ü¸®º»ºÎ |
|
¹Ì±¹ CDC |
|
WHO |
|
Ç¥ 4. ±¹¿Ü Äڷγª°¨¿°(COVID-19) ÃֽŠÇмúÁ¤º¸ »çÀÌÆ®
References
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China (2020).
The Lancet, DOI:https://doi.org/10.1016/S0140-6736(20)30183-5
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext
Coronavirus disease 2019 (COVID-19) Situation Report – 34
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200223-sitrep-34-covid-19.pdf?sfvrsn=44ff8fd3_2
Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics (2020). The Lancet, February 13, 2020, https://doi.org/10.1016/S2213-2600(20)30071-0